Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers.
Tacket CO, Sztein MB, Wasserman SS, Losonsky G, Kotloff KL, Wyant TL, Nataro JP, Edelman R, Perry J, Bedford P, Brown D, Chatfield S, Dougan G, Levine MM.
Tacket CO, et al. Among authors: chatfield s.
Infect Immun. 2000 Mar;68(3):1196-201. doi: 10.1128/IAI.68.3.1196-1201.2000.
Infect Immun. 2000.
PMID: 10678926
Free PMC article.
Clinical Trial.